← Open Payments lookup

BRIAN PAUGH: Open Payments

NPI 1225430416 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$840 in 49 payments from 14 companies in 2025. Trend: 2023 $1,769 · 2024 $798 · 2025 $840

Food & beverage: $760Education: $80
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$165
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$164
ABBVIE INC.15$149
Otsuka America Pharmaceutical, Inc.3$53
Lundbeck LLC2$52
Supernus Pharmaceuticals, Inc.2$48
Neurocrine BioSciences, Inc.2$44
Collegium Pharmaceutical, Inc.3$43
Vanda Pharmaceuticals Inc.2$40
Neos Therapeutics, LP1$18

Products named: CAPLYTA, VRAYLAR, REXULTI, AUSTEDO XR, Qelbree, INGREZZA, Jornay PM, HETLIOZ.

Industry payments across IA — which companies pay providers there.